Biotechnology & Medical Research Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 1,302 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Industry Group Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Biotechnology & Medical Research Large (169.4bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (134.0bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (65.5bn) 0 No activity — 0–15%
NL argenx SE (ARGX)
Biotechnology & Medical Research Large (58.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (51.0bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (43.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Seagen Inc (SGEN)
Biotechnology & Medical Research Large (43.2bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (38.7bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (37.8bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (34.5bn) 0 No activity — 0–15%
US Moderna Inc (MRNA)
Biotechnology & Medical Research Large (32.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (26.1bn) -6–10 -$100M+ -0–15% 15–50%
US Insmed Inc (INSM)
Biotechnology & Medical Research Large (24.5bn) -1–5 -$1M–$10M -0–15% 0–15%
DE Biontech SE (BNTX)
Biotechnology & Medical Research Large (23.3bn) -1–5 -$1M–$10M -0–15% 50%+
US Incyte Corp (INCY)
Biotechnology & Medical Research Large (22.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (22.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (21.6bn) -11–20 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (20.3bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (20.0bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (18.2bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (17.7bn) 1–5 -$1M–$10M -0–15% 0–15%
DK Genmab A/S (GMAB)
Biotechnology & Medical Research Large (16.5bn) 0 No activity — —
Biotechnology & Medical Research Large (15.5bn) -1–5 -$1M–$10M -0–15% 15–50%
Biotechnology & Medical Research Large (14.0bn) 0 No activity — 0–15%
US Exelixis Inc (EXEL)
Biotechnology & Medical Research Large (14.0bn) -6–10 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (12.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (12.6bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (12.6bn) 0 No activity — 15–50%
FR Abivax SA (ABVX)
Biotechnology & Medical Research Large (12.3bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (12.1bn) 0 No activity — 0–15%
US MyoKardia Inc (MYOK)
Biotechnology & Medical Research Large (12.0bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (11.8bn) 1–5 $100M+ 0–15% 50%+
Biotechnology & Medical Research Large (11.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (11.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (11.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (11.0bn) -6–10 -$1M–$10M -0–15% 15–50%
Biotechnology & Medical Research Large (10.9bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (10.9bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (10.1bn) 0 No activity — 0–15%
US Nuvalent Inc (NUVL)
Biotechnology & Medical Research Mid (9.8bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (9.6bn) 0 No activity — 15–50%
Biotechnology & Medical Research Mid (9.1bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (9.0bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.9bn) 0 No activity — 0–15%
IE ICON PLC (ICLR)
Biotechnology & Medical Research Mid (8.9bn) 0 No activity — 0–15%
IE Alkermes Plc (ALKS)
Biotechnology & Medical Research Mid (8.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (8.8bn) 0 No activity — 0–15%
US ImmunoGen Inc (IMGN)
Biotechnology & Medical Research Mid (8.7bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.6bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Mid (8.5bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Mid (8.4bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.2bn) -6–10 -$10M–$100M -0–15% 50%+
Biotechnology & Medical Research Mid (8.2bn) -1–5 -$100M+ -0–15% 0–15%
US Vaxcyte Inc (PCVX)
Biotechnology & Medical Research Mid (8.2bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.2bn) 0 No activity — 50%+
Biotechnology & Medical Research Mid (7.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (7.7bn) 0 No activity — 15–50%
Biotechnology & Medical Research Mid (7.4bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (7.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (7.1bn) -1–5 -$100K–$1M -0–15% 0–15%
US Liquidia Corp (LQDA)
Biotechnology & Medical Research Mid (7.0bn) -1–5 -$100M+ -0–15% 0–15%
Biotechnology & Medical Research Mid (7.0bn) 0 No activity — 0–15%
US Merus NV (MRUS)
Biotechnology & Medical Research Mid (6.8bn) 0 No activity — 50%+
NL Qiagen NV (QIA)
Biotechnology & Medical Research Mid (6.8bn) 1–5 $1M–$10M 0–15% 0–15%
Biotechnology & Medical Research Mid (6.8bn) -1–5 -$100K–$1M -0–15% 0–15%
US Arcellx Inc (ACLX)
Biotechnology & Medical Research Mid (6.7bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (6.5bn) 1–5 $10M–$100M 0–15% 0–15%
Biotechnology & Medical Research Mid (6.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Mid (6.2bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (6.1bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (5.9bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (5.7bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (5.6bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (5.5bn) 0 No activity — 15–50%
Biotechnology & Medical Research Mid (5.5bn) -1–5 -$1M–$10M -0–15% 15–50%
Biotechnology & Medical Research Mid (5.5bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (5.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (5.4bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (5.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (5.3bn) -1–5 -$100K–$1M -0–15% 0–15%
US Celcuity Inc (CELC)
Biotechnology & Medical Research Mid (5.2bn) -1–5 -$100M+ -0–15% 0–15%
Biotechnology & Medical Research Mid (4.9bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (4.8bn) 0 No activity — 0–15%
US Veracyte Inc (VCYT)
Biotechnology & Medical Research Mid (4.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Mid (4.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Mid (4.6bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (4.5bn) 0 No activity — 0–15%
US Erasca Inc (ERAS)
Biotechnology & Medical Research Mid (4.4bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (4.3bn) -1–5 -< $100K -0–15% 0–15%
IN Biocon Ltd (BIOCON)
Biotechnology & Medical Research Mid (4.3bn) 0 No activity — 50%+
Biotechnology & Medical Research Mid (4.2bn) 0 No activity — 0–15%
US TESARO Inc (TSRO)
Biotechnology & Medical Research Mid (4.1bn) 0 No activity — —
US Metsera Inc (MTSR)
Biotechnology & Medical Research Mid (4.1bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (4.1bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (4.1bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (4.1bn) 0 No activity — 0–15%